Study Reports Antibiotic Prices Inflated By Limited Competition in Drug Sales
Council on Econ Priorities repts that limited scope of competition among drug cos in sale of 7 antibiotics cost consumers at least $180âmillion a yr; attributes pricing primarily to patent system, which leaves original brand name of drug imprinted on drs' memories, and to promotional efforts of drug cos; spokesman for Sen Gaylord Nelson, head of Sen Small Business Com, says hearings will be held in next session of Cong into possible antitrust violations in pricing of prescription drugs; Pharmaceutical Mfrs Assn pres C Joseph Stetler says rept appears to favor reduction of drug indus to commodities supplier with price as sole criterian; says such a course would bring virtual end to drug research and maintaining overâall standards of excellence (M)